Estrella Immunopharma (ESLA) Debt Ratio (2022 - 2023)
Estrella Immunopharma's (ESLA) Debt Ratio stood at 0.01 in Q1 2024, down 87.8% from the prior quarter.
Powered by 
Analysis
Estrella Immunopharma (ESLA) Debt Ratio (2022 - 2023) Analysis & Trends
For FY2023, Estrella Immunopharma's Debt Ratio came in at 0.09.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 0.24 |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 0.52 |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 0.42 |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 0.31 |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 0.00 |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 0.60 |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 0.53 |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Estrella Immunopharma | 20.44 Mn | 15.36 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 0.01 |
| Jun 30, 2023 | 0.09 |
| Mar 31, 2023 | 0.01 |
| Sep 30, 2022 | 0.01 |
API Access
Estrella Immunopharma Debt Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=debt-ratio&ticker=ESLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "debt-ratio", "ticker": "ESLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=debt-ratio&ticker=ESLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();